Current and future challenges of subcutaneous and sublingual allergy immunotherapy for allergists in the United States

Ann Allergy Asthma Immunol. 2018 Sep;121(3):278-280. doi: 10.1016/j.anai.2017.12.013. Epub 2018 Jun 12.

Author

Harold S Nelson¹

Affiliation

¹ National Jewish Health, University of Colorado Denver School of Medicine, Denver, Colorado. Electronic address: nelson@njhealth.org.

PMID: 29409924
DOI: 10.1016/j.anai.2017.12.013

No abstract available

MeSH terms

Allergens / administration & dosage*
Allergens / therapeutic use*
Asthma / therapy*
Dermatitis, Atopic / therapy
Humans
Injections, Subcutaneous
Rhinitis, Allergic / therapy*
Sublingual Immunotherapy / adverse effects*
Sublingual Immunotherapy / methods
United States

Substances

Allergens